Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy

Fig. 1

Occurrence of EndMT and increase in PFN2 expression in DN patients. A HE staining and Masson staining in renal biopsy specimens of DN patients and control participants. Magnification: ×20. Scale bar: 20 μM. (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n = 20 for the control group, n = 7 for the DN2 group, n = 7 for the DN3 group, n = 6 for the DN4 group) B Immunostaining of CD31, vimentin, αSMA and S100A4 and PFN2 in renal biopsy specimens of DN patients and control participants. Magnification: ×20. Scale bar: 20 μM. (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n = 20 for the control group, n = 7 for the DN2 group, n = 7 for the DN3 group, n = 6 for the DN4 group)

Back to article page